Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT · BSE: 524742 · Pharmaceuticals & Biotechnology · 25 announcements

Share price
₹2,638.00
Market cap
₹20,052 Cr
Revenue (annual)
₹2,187 Cr
Net profit (annual)
₹641.2 Cr
P/E (TTM)
30.1×Sector 47.4×
Promoter holding
70.57%+0.00% QoQ
FII holding
5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:56 IST BSE
Other Announcement

Caplin Point Laboratories Other Announcement

Caplin Point Laboratories Limited shared a weblink for its 35th AGM Notice and Annual Report for FY 2025-26. The communication targets shareholders with unregistered email addresses.

14:06 IST BSE
Other Announcement

Caplin Point Laboratories Other Announcement

Caplin Point Laboratories Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing details distributions across promoter and public categories.

17:16 IST BSE
Other Announcement

Caplin Point Laboratories Other Announcement

Caplin Point Laboratories filed its Annual Secretarial Compliance Report for FY2026. The report confirms overall regulatory compliance with minor procedural delays waived by exchanges.

15:20 IST BSE
Other Announcement

Caplin Point Laboratories Other Announcement

Caplin Point Laboratories submitted a compliance certificate under Regulation 74(5) of SEBI Regulations for the quarter ended March 31, 2026. The Registrar and Transfer Agent confirmed that security certificates received for dematerialisation were mutilated and cancelled after due verification. This is a routine administrative filing with no direct financial impact.